🟢 Strong Evidence
The U.S. Food and Drug Administration (FDA) has expanded a recall of reprocessed electrophysiology and ultrasound catheters manufactured by Medline Industries due to potential contamination with residual particulates. The contamination poses a risk of serious adverse events including infection, embolism, and thrombosis in patients receiving these devices.
Key takeaways
- Medline Industries reprocessed catheters may contain residual particulates that escaped sterilization
- Three serious risks identified: infection, arterial or venous embolism, and thrombosis
- FDA classifies this as a Class II recall affecting electrophysiology and ultrasound catheter lines
- Healthcare providers are advised to quarantine affected inventory and notify patients who received these devices
- Medline is providing replacement devices and issuing refunds for affected units
FDA Device Recall Classifications and Risk Levels
FDA categorizes medical device recalls into three classes based on severity and patient safety impact
Source: FDA, Medical Device Recalls | Georgian Medical Journal News
Contamination Mechanism and Clinical Significance
The recalled catheters are reprocessed devices—medical instruments that have been used previously, then cleaned and sterilized for reuse. According to the FDA recall notice, the reprocessing protocol at Medline Industries failed to adequately remove particulate matter before sterilization, leaving residual contamination on device surfaces.
When inserted into patients’ vasculature or cardiac tissue, these particulates can lodge in small vessels or cardiac chambers, triggering three distinct clinical complications. Infection risk arises from bacterial colonization on particulate surfaces; embolism occurs when particulates become lodged in arterial or venous systems, obstructing blood flow; and thrombosis develops as the body’s clotting cascade is activated in response to foreign material. All three conditions require emergency medical intervention and carry risk of serious morbidity and mortality.
Scope of Recall and Affected Device Categories
The recall encompasses reprocessed electrophysiology catheters—devices used in cardiac rhythm management, ablation procedures, and diagnostic electrophysiology studies—and reprocessed ultrasound catheters used in intracardiac echocardiography and vascular imaging. The expansion of the original recall indicates Medline Industries identified contamination across multiple catheter product lines, suggesting a systemic failure in the reprocessing facility’s quality assurance protocols.
Healthcare facilities using Medline reprocessed catheters have been instructed to immediately quarantine affected inventory. The FDA guidance requires providers to cross-reference their inventory against serial numbers and lot codes provided in the recall documentation, and to contact patients who may have received these devices for clinical follow-up and monitoring for adverse symptoms.
Manufacturer Response and Replacement Protocol
Medline Industries is providing replacement catheters at no cost to affected healthcare institutions and issuing refunds for recalled units. The company has also established a process for healthcare providers to report any adverse events associated with the recalled devices, feeding back into post-market surveillance systems monitored by the FDA.
For clinical context, see related coverage on Quality & Safety and Pharmacy & Prescribing for ongoing medical device safety updates.
Reprocessed medical devices present a lower cost alternative to single-use devices but require rigorous quality control protocols to prevent contamination-related adverse events. Failures in reprocessing sterilization can introduce particulate matter that poses serious risks of infection, embolism, and thrombosis.
— FDA Medical Device Safety Oversight (2026)
What this means
Frequently asked questions
What are reprocessed medical devices, and why are they used?
Reprocessed devices are FDA-cleared medical instruments that have been used in a patient, then cleaned, tested, sterilized, and repackaged for another patient. Hospitals use them to reduce costs, as single-use devices can be expensive. However, reprocessing must meet strict FDA quality standards to ensure safety. This recall shows that when reprocessing protocols fail, contamination risks can exceed those of new devices.
How do I know if I received one of these recalled catheters?
Your hospital or clinic should contact you directly if you received a recalled Medline catheter, as they have records of procedures and device serial numbers. If you had an electrophysiology procedure (such as an ablation, pacemaker implant, or rhythm study) or intracardiac ultrasound between the dates specified in the FDA recall notice, ask your provider to confirm which catheters were used. You can also check the FDA recall notice for lot numbers and serial codes.
What symptoms should I watch for if I received one of these devices?
Seek immediate medical attention if you develop fever, chills, chest pain, shortness of breath, palpitations, localized swelling or redness at catheter insertion sites, or signs of stroke (sudden weakness, slurred speech, facial drooping). These could indicate infection, thrombosis, or embolism. Do not delay—call emergency services or go to an emergency department, and inform providers that you received a Medline reprocessed catheter.
The FDA continues to monitor post-market reports related to this recall and may expand the scope if additional contamination is detected in other Medline reprocessed product lines. Healthcare systems should maintain heightened vigilance when sourcing reprocessed catheters and consider the long-term reliability and safety profile of manufacturers when making procurement decisions. Strengthening quality assurance in reprocessing facilities remains a critical public health priority as healthcare systems balance cost pressures with patient safety imperatives.
Source: FDA Medical Device Recalls: Catheter Recall Expansion — Medline Industries
Was this article helpful?
Related Coverage
